Detalhe da pesquisa
1.
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
Am J Clin Dermatol
; 24(5): 821-835, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341961
2.
Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation.
Dermatol Ther (Heidelb)
; 12(9): 2063-2075, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917057
3.
Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial.
PLoS One
; 17(2): e0263214, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130291